Literature DB >> 17639351

Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.

A J Tallett1, J E Blundell, R J Rodgers.   

Abstract

RATIONALE: Although the CB1 receptor antagonist/inverse agonist rimonabant acutely suppresses food intake in rodents, the behavioural specificity of this effect remains unclear.
OBJECTIVES: To profile the behavioural effects of rimonabant in a free-feeding context.
MATERIALS AND METHODS: Videoanalysis was employed to characterise the effects of acute rimonabant (1.5 and 3.0 mg/kg, IP) on the behaviour of non-deprived male rats exposed to palatable mash. Data were also collected on post-treatment weight gain, and, as prolonged appetite suppression has been found after single dosing with compounds of this series, rats were reassessed (drug-free) for food intake 7 days after initial testing.
RESULTS: Both doses of rimonabant not only decreased mash consumption (44-55%) but also reduced 24-h weight gain. Although videoanalysis confirmed the inhibitory effects of rimonabant on feeding behaviour, it also revealed concurrent reductions in locomotion, rearing and sniffing as well as substantial (up to tenfold) and dose-dependent increases in grooming and scratching. Timecourse analyses further revealed that rimonabant dose-dependently induced frequent episodes of atypical scratching that waned over the test but which were succeeded by prolonged and behaviourally disruptive grooming. Finally, as groups did not differ in mash consumption on retest, any prolonged anorectic effect of acute rimonabant dissipates within 7 days of treatment.
CONCLUSIONS: The anorectic response to rimonabant in male rats would appear to be due largely to response competition. This parsimonious conclusion is supported by the less profound (although still significant) increases in scratching and grooming observed in rats treated with a sub-anorectic dose (0.5 mg/kg) of the compound.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639351     DOI: 10.1007/s00213-007-0880-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  91 in total

Review 1.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

Review 2.  Cannabinoids, opioids and eating behavior: the molecular face of hedonism?

Authors:  Daniela Cota; Matthias H Tschöp; Tamas L Horvath; Allen S Levine
Journal:  Brain Res Rev       Date:  2005-12-20

3.  Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol.

Authors:  J E Brown; M Kassouny; J K Cross
Journal:  Behav Biol       Date:  1977-05

4.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Authors:  Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; George Kunos
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Authors:  L Hanus; S Abu-Lafi; E Fride; A Breuer; Z Vogel; D E Shalev; I Kustanovich; R Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

6.  Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

Authors:  M Navarro; E Hernández; R M Muñoz; I del Arco; M A Villanúa; M R Carrera; F Rodríguez de Fonseca
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

Review 7.  The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

Authors:  A C Porter; C C Felder
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

8.  Endogenous cannabinoids and appetite.

Authors:  T C Kirkham; C M Williams
Journal:  Nutr Res Rev       Date:  2001-06       Impact factor: 7.800

9.  Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.

Authors:  Suzanne Higgs; Claire M Williams; Tim C Kirkham
Journal:  Psychopharmacology (Berl)       Date:  2002-11-22       Impact factor: 4.530

10.  Anandamide, an endogenous cannabinoid, has a very low physical dependence potential.

Authors:  M D Aceto; S M Scates; R K Razdan; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

View more
  24 in total

1.  The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.

Authors:  Garron T Dodd; Giacomo Mancini; Beat Lutz; Simon M Luckman
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor.

Authors:  Peter J McLaughlin; Julia E Jagielo-Miller; Emily S Plyler; Kerry K Schutte; V Kiran Vemuri; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2017-02-01       Impact factor: 4.530

3.  The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.

Authors:  Janel Hodge; Joshua P Bow; Kimberly S Plyler; V Kiran Vemuri; Ania Wisniecki; John D Salamone; Alexandros Makriyannis; Peter J McLaughlin
Journal:  Behav Brain Res       Date:  2008-06-17       Impact factor: 3.332

Review 4.  The utility of animal models to evaluate novel anti-obesity agents.

Authors:  Steven P Vickers; Helen C Jackson; Sharon C Cheetham
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 5.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

6.  Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2012-11-10       Impact factor: 4.530

7.  Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2013-03-01       Impact factor: 4.530

8.  Glucocorticoid receptor antagonism disrupts the reconsolidation of social reward-related memories in rats.

Authors:  E J Marijke Achterberg; Viviana Trezza; Louk J M J Vanderschuren
Journal:  Behav Pharmacol       Date:  2014-06       Impact factor: 2.293

9.  Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.

Authors:  K S Sink; K N Segovia; J Sink; P A Randall; L E Collins; M Correa; E J Markus; V K Vemuri; A Makriyannis; J D Salamone
Journal:  Eur Neuropsychopharmacol       Date:  2009-12-16       Impact factor: 4.600

10.  Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.

Authors:  Joyonna C Gamble-George; Jordan R Conger; Nolan D Hartley; Prerna Gupta; Joshua J Sumislawski; Sachin Patel
Journal:  Psychopharmacology (Berl)       Date:  2013-03-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.